Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder

Neuromyelitis optica spectrum disorder (NMOSD) is a frequently disabling neuroinflammatory syndrome with a relapsing course. Blood-based disease severity and prognostic biomarkers for NMOSD are a yet unmet clinical need. Here, we evaluated serum glial fibrillary acidic protein (sGFAP) and neurofilam...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schindler, Patrick (VerfasserIn) , Grittner, Ulrike (VerfasserIn) , Oechtering, Johanna (VerfasserIn) , Leppert, David (VerfasserIn) , Siebert, Nadja (VerfasserIn) , Duchow, Ankelien S. (VerfasserIn) , Oertel, Frederike Cosima (VerfasserIn) , Asseyer, Susanna (VerfasserIn) , Kuchling, Joseph (VerfasserIn) , Zimmermann, Hanna (VerfasserIn) , Brandt, Alexander Ulrich (VerfasserIn) , Benkert, Pascal (VerfasserIn) , Reindl, Markus (VerfasserIn) , Jarius, Sven (VerfasserIn) , Paul, Friedemann (VerfasserIn) , Bellmann-Strobl, Judith (VerfasserIn) , Kuhle, Jens (VerfasserIn) , Ruprecht, Klemens (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 01 May 2021
In: Journal of neuroinflammation
Year: 2021, Jahrgang: 18, Pages: 1-14
ISSN:1742-2094
DOI:10.1186/s12974-021-02138-7
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12974-021-02138-7
Volltext
Verfasserangaben:Patrick Schindler, Ulrike Grittner, Johanna Oechtering, David Leppert, Nadja Siebert, Ankelien S. Duchow, Frederike C. Oertel, Susanna Asseyer, Joseph Kuchling, Hanna G. Zimmermann, Alexander U. Brandt, Pascal Benkert, Markus Reindl, Sven Jarius, Friedemann Paul, Judith Bellmann-Strobl, Jens Kuhle and Klemens Ruprecht

MARC

LEADER 00000caa a2200000 c 4500
001 1760473405
003 DE-627
005 20230814113715.0
007 cr uuu---uuuuu
008 210615s2021 xx |||||o 00| ||eng c
024 7 |a 10.1186/s12974-021-02138-7  |2 doi 
035 |a (DE-627)1760473405 
035 |a (DE-599)KXP1760473405 
035 |a (OCoLC)1341416415 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schindler, Patrick  |e VerfasserIn  |4 aut 
245 1 0 |a Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder  |c Patrick Schindler, Ulrike Grittner, Johanna Oechtering, David Leppert, Nadja Siebert, Ankelien S. Duchow, Frederike C. Oertel, Susanna Asseyer, Joseph Kuchling, Hanna G. Zimmermann, Alexander U. Brandt, Pascal Benkert, Markus Reindl, Sven Jarius, Friedemann Paul, Judith Bellmann-Strobl, Jens Kuhle and Klemens Ruprecht 
264 1 |c 01 May 2021 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.06.2021 
520 |a Neuromyelitis optica spectrum disorder (NMOSD) is a frequently disabling neuroinflammatory syndrome with a relapsing course. Blood-based disease severity and prognostic biomarkers for NMOSD are a yet unmet clinical need. Here, we evaluated serum glial fibrillary acidic protein (sGFAP) and neurofilament light (sNfL) as disease severity and prognostic biomarkers in patients with aquaporin-4 immunoglobulin (Ig)G positive (AQP4-IgG+) NMOSD. 
650 4 |a Aquaporin-4 immunoglobulin G 
650 4 |a Biomarker 
650 4 |a Glial fibrillary acidic protein 
650 4 |a Myelin oligodendrocyte glycoprotein immunoglobulin G 
650 4 |a Neurofilament light chain protein 
650 4 |a Neuromyelitis optica spectrum disorder 
650 4 |a Serum 
700 1 |a Grittner, Ulrike  |d 1972-  |e VerfasserIn  |0 (DE-588)1150982225  |0 (DE-627)1011197669  |0 (DE-576)497347296  |4 aut 
700 1 |a Oechtering, Johanna  |d 1983-  |e VerfasserIn  |0 (DE-588)1025561848  |0 (DE-627)722930828  |0 (DE-576)370506960  |4 aut 
700 1 |a Leppert, David  |e VerfasserIn  |4 aut 
700 1 |a Siebert, Nadja  |e VerfasserIn  |4 aut 
700 1 |a Duchow, Ankelien S.  |e VerfasserIn  |4 aut 
700 1 |a Oertel, Frederike Cosima  |e VerfasserIn  |0 (DE-588)1228123144  |0 (DE-627)1749470772  |4 aut 
700 1 |a Asseyer, Susanna  |e VerfasserIn  |0 (DE-588)1213671418  |0 (DE-627)1724482645  |4 aut 
700 1 |a Kuchling, Joseph  |d 1989-  |e VerfasserIn  |0 (DE-588)1081792647  |0 (DE-627)846672472  |0 (DE-576)454797362  |4 aut 
700 1 |a Zimmermann, Hanna  |e VerfasserIn  |0 (DE-588)1167007085  |0 (DE-627)1030850534  |0 (DE-576)510997287  |4 aut 
700 1 |a Brandt, Alexander Ulrich  |d 1975-  |e VerfasserIn  |0 (DE-588)1062902068  |0 (DE-627)80700930X  |0 (DE-576)420249605  |4 aut 
700 1 |a Benkert, Pascal  |e VerfasserIn  |4 aut 
700 1 |a Reindl, Markus  |e VerfasserIn  |0 (DE-588)1158607156  |0 (DE-627)1020597453  |0 (DE-576)504248413  |4 aut 
700 1 |a Jarius, Sven  |e VerfasserIn  |0 (DE-588)1054615918  |0 (DE-627)791654818  |0 (DE-576)410367478  |4 aut 
700 1 |a Paul, Friedemann  |d 1967-  |e VerfasserIn  |0 (DE-588)120885476  |0 (DE-627)080947700  |0 (DE-576)292431309  |4 aut 
700 1 |a Bellmann-Strobl, Judith  |e VerfasserIn  |4 aut 
700 1 |a Kuhle, Jens  |d 1973-  |e VerfasserIn  |0 (DE-588)128445696  |0 (DE-627)372675727  |0 (DE-576)187294534  |4 aut 
700 1 |a Ruprecht, Klemens  |d 1971-  |e VerfasserIn  |0 (DE-588)121955699  |0 (DE-627)081645511  |0 (DE-576)293016720  |4 aut 
773 0 8 |i Enthalten in  |t Journal of neuroinflammation  |d London : BioMed Central, 2004  |g 18(2021), Artikel-ID 105, Seite 1-14  |h Online-Ressource  |w (DE-627)391784781  |w (DE-600)2156455-3  |w (DE-576)12192985X  |x 1742-2094  |7 nnas  |a Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder 
773 1 8 |g volume:18  |g year:2021  |g elocationid:105  |g pages:1-14  |g extent:14  |a Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder 
856 4 0 |u https://doi.org/10.1186/s12974-021-02138-7  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210615 
993 |a Article 
994 |a 2021 
998 |g 1054615918  |a Jarius, Sven  |m 1054615918:Jarius, Sven  |d 910000  |d 911100  |e 910000PJ1054615918  |e 911100PJ1054615918  |k 0/910000/  |k 1/910000/911100/  |p 14 
999 |a KXP-PPN1760473405  |e 3938585269 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"01 May 2021"}],"relHost":[{"pubHistory":["1.2004 -"],"titleAlt":[{"title":"JNI"}],"part":{"volume":"18","text":"18(2021), Artikel-ID 105, Seite 1-14","extent":"14","pages":"1-14","year":"2021"},"id":{"eki":["391784781"],"issn":["1742-2094"],"zdb":["2156455-3"]},"origin":[{"publisher":"BioMed Central","dateIssuedKey":"2004","publisherPlace":"London","dateIssuedDisp":"2004-"}],"note":["Gesehen am 12.07.10"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"subtitle":"JNI","title":"Journal of neuroinflammation","title_sort":"Journal of neuroinflammation"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"391784781","disp":"Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorderJournal of neuroinflammation"}],"person":[{"family":"Schindler","given":"Patrick","role":"aut","display":"Schindler, Patrick"},{"given":"Ulrike","role":"aut","family":"Grittner","display":"Grittner, Ulrike"},{"display":"Oechtering, Johanna","family":"Oechtering","role":"aut","given":"Johanna"},{"display":"Leppert, David","role":"aut","given":"David","family":"Leppert"},{"given":"Nadja","role":"aut","family":"Siebert","display":"Siebert, Nadja"},{"display":"Duchow, Ankelien S.","family":"Duchow","given":"Ankelien S.","role":"aut"},{"display":"Oertel, Frederike Cosima","role":"aut","given":"Frederike Cosima","family":"Oertel"},{"role":"aut","given":"Susanna","family":"Asseyer","display":"Asseyer, Susanna"},{"display":"Kuchling, Joseph","family":"Kuchling","given":"Joseph","role":"aut"},{"display":"Zimmermann, Hanna","given":"Hanna","role":"aut","family":"Zimmermann"},{"display":"Brandt, Alexander Ulrich","family":"Brandt","role":"aut","given":"Alexander Ulrich"},{"family":"Benkert","given":"Pascal","role":"aut","display":"Benkert, Pascal"},{"family":"Reindl","given":"Markus","role":"aut","display":"Reindl, Markus"},{"family":"Jarius","role":"aut","given":"Sven","display":"Jarius, Sven"},{"given":"Friedemann","role":"aut","family":"Paul","display":"Paul, Friedemann"},{"display":"Bellmann-Strobl, Judith","family":"Bellmann-Strobl","role":"aut","given":"Judith"},{"family":"Kuhle","given":"Jens","role":"aut","display":"Kuhle, Jens"},{"given":"Klemens","role":"aut","family":"Ruprecht","display":"Ruprecht, Klemens"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 15.06.2021"],"title":[{"title_sort":"Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder","title":"Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder"}],"physDesc":[{"extent":"14 S."}],"recId":"1760473405","name":{"displayForm":["Patrick Schindler, Ulrike Grittner, Johanna Oechtering, David Leppert, Nadja Siebert, Ankelien S. Duchow, Frederike C. Oertel, Susanna Asseyer, Joseph Kuchling, Hanna G. Zimmermann, Alexander U. Brandt, Pascal Benkert, Markus Reindl, Sven Jarius, Friedemann Paul, Judith Bellmann-Strobl, Jens Kuhle and Klemens Ruprecht"]},"id":{"doi":["10.1186/s12974-021-02138-7"],"eki":["1760473405"]}} 
SRT |a SCHINDLERPSERUMGFAPA0120